Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT

Severe combined immunodeficiency (SCID) is effectively treated with hematopoietic cell transplantation (HCT), with overall survival approaching 90% in contemporary reports. However, survivors are at risk for developing late complications because of the variable durability of high-quality immune func...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Heimall, Jennifer, Buckley, Rebecca H., Puck, Jennifer, Fleisher, Thomas A., Gennery, Andrew R., Haddad, Elie, Neven, Benedicte, Slatter, Mary, Roderick, Skinner, Baker, K. Scott, Dietz, Andrew C., Duncan, Christine, Griffith, Linda M., Notarangelo, Luigi, Pulsipher, Michael A., Cowan, Morton J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015789/
https://ncbi.nlm.nih.gov/pubmed/28479164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.026
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky